| Dr Yin Moe Thwe, MD | |
|
1 Shrader St Ste 500, San Francisco, CA 94117-1044 | |
| (415) 831-6441 | |
| (415) 831-6443 |
| Full Name | Dr Yin Moe Thwe |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 1 Shrader St Ste 500, San Francisco, California |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033357033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A106837 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Laguna Honda Hospital & Rehabilitation Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City And County Of San Francisco | 1658280748 | 265 |
| Vibra Physicians Llc | 8921233933 | 68 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | Marin Hospitalist Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041753 PECOS PAC ID: 1456257146 Enrollment ID: O20031211001139 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | Galen Inpatient Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689320459 PECOS PAC ID: 3678464633 Enrollment ID: O20040322000680 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | City & County Of San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982737524 PECOS PAC ID: 1658280748 Enrollment ID: O20050309000770 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | Aung Thu Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154468924 PECOS PAC ID: 4688694078 Enrollment ID: O20051130000503 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | Vibra Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659705424 PECOS PAC ID: 8921233933 Enrollment ID: O20140325000558 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Entity Name | San Francisco Unified Physicians Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982104162 PECOS PAC ID: 8426310004 Enrollment ID: O20180319001999 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yin Moe Thwe, MD 245 Laursen St, Hemet, CA 92543-4437 Ph: (951) 929-5537 | Dr Yin Moe Thwe, MD 1 Shrader St Ste 500, San Francisco, CA 94117-1044 Ph: (415) 831-6441 |
News Archive
The American Association of Critical-Care Nurses (AACN) launches mobile-friendly access to the websites of its award-winning bimonthly journals, American Journal of Critical Care and Critical Care Nurse.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.
As of late May, COVID-19 has killed more than 325,000 people around the world. Even though the worst seems to be over for countries like China and South Korea, public health experts warn that cases and fatalities will continue to surge in many parts of the world.
Wearing a face-mask while out-and-about on public transport, in shops and in crowded places could help protect people from COVID-19 - according to new research from the University of East Anglia.
› Verified 7 days ago
Miteshkumar Patel, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Divisadero St, San Francisco, CA 94117 Phone: 404-545-3885 | |
Hunter Kegan Holt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1569 Sloat Blvd Ste 333, San Francisco, CA 94132 Phone: 415-353-9339 Fax: 415-353-3450 | |
Dr. Patricia Jean Galamba, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 909 Hyde St, Suite 410, San Francisco, CA 94109 Phone: 415-928-4920 Fax: 415-474-7654 | |
Dr. Thang Cao Nguyen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Capp St, San Francisco, CA 94110 Phone: 415-621-8051 | |
Dr. Barbara R Curry-kaufman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 236 W Portal Ave # 18, San Francisco, CA 94127 Phone: 928-853-0344 Fax: 415-584-9960 | |
Dr. Jayshree Chander, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4 Embarcadero Ctr Lbby, San Francisco, CA 94111 Phone: 415-529-4566 Fax: 415-291-0489 | |
Dr. Weiwen Zheng, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 Stockton St, Suite 328, San Francisco, CA 94108 Phone: 415-398-2698 Fax: 415-398-2686 |